Beta Agonist / Anticholinergic Combinations

Combivent Respimat (ipratropium bromide and albuterol sulfate) is a beta-2 agonist / anticholinergic combination used to treat COPD. The combination of ipratropium and albuterol eases constriction of the airways by relaxing the surrounding smooth muscle. Combivent Respimat replaces the Combivent metered-dose inhaler, which was taken off the market to comply with the Clean Air Act. There is no generic alternative available. However, DuoNeb (generic ipratropium/albuterol) has the same combination of active ingredients for use with a nebulizer.

Prices for 1 inhaler (200 doses) of Combivent 18mcg/103mcg (brand)

Get drug prices near you

Form Inhaler

Savings Tips

  • Manufacturer Assistance Program: Financial assistance is available for eligible patients. Learn more
  • Availability: Combivent was discontinued in July 2013 and replaced with Combivent Respimat. Learn more

Combivent is no longer available

Combivent has been discontinued by the manufacturer and is no longer available.

We encourage you to look at other drugs in the Beta Agonist / Anticholinergic Combinations class that also treat COPD, and to discuss other options with your doctor.

We also offer the latest news and other information about Combivent.

Other COPD Drugs

Copyright ©2015 GoodRx, Inc.

GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.